Implementation of the global strategy and plan of action on public health, innovation and intellectual property: report of a global survey 2022

World Health Organization

2024年6月 · World Health Organization

关于此电子书

The 2030 Agenda for Sustainable Development recognizes the need for research and development into and access to affordable essential medicines and vaccines for the communicable and noncommunicable diseases that primarily affect developing countries. Target 3.b is to support research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.

The aim of the Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property (GSPA-PHI), adopted in 2008 (2), is to promote new thinking on innovation and access to medicines and to secure an enhanced and sustainable basis for needs-driven essential health research and development relevant to diseases that disproportionately affect developing countries.